SCHEMBL30890761

SCHEMBL30890761

[2H]C1N(CCCC)[C@@H](C)CC12Oc1ccccc1NC2=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ POLB P06746 2/20 0.34
▸ BRD4 O60885 1/20 0.34
▸ CREBBP Q92793 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ MGAM O43451 1/20 0.34
▸ SI P14410 1/20 0.34
▸ MGAM2 Q2M2H8 1/20 0.34
▸ USP2 O75604 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ PARP1 P09874 1/20 0.33
▸ PSEN1 P49768 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30890558 0.83 OTUD7B (0.43) GAAHPGDALDH1A1POLBBRD4
SCHEMBL30890782 0.76 PDE1A (0.33) —
SCHEMBL16163265 0.67 ALOX5 (0.43) GAAMAPTMEN1ALDH1A1KMT2A
SCHEMBL30890444 0.65 POLB (0.36) GAAHPGDMAPTTDP1KDM4E
SCHEMBL30890758 0.65 HTR4 (0.35) —
SCHEMBL30890412 0.64 HSD17B10 (0.36) GAAHPGDMAPTTDP1KDM4E
SCHEMBL26770985 0.63 ALDH1A1 (0.44) GAAMAPTMEN1ALDH1A1KMT2A
SCHEMBL25936295 0.63 ALDH1A1 (0.44) GAAMAPTMEN1ALDH1A1KMT2A
SCHEMBL15337500 0.62 HSD11B1 (0.40) GAAMAPTMEN1KMT2APOLB
SCHEMBL24306740 0.60 MAPT (0.42) GAAHPGDMAPTTDP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4612156-A1 ANTI-VIRAL COMPOUNDS Aligos Therapeutics, Inc. (US) 2025-09-10 — — EP disclosed
WO-2024097296-A1 ANTI-VIRAL COMPOUNDS ALIGOS THERAPEUTICS, INC. (US) 2024-05-10 — — WO disclosed
Send feedback